Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TVTX - Travere Therapeutics, Inc.
99.3 M
LAST VALUE
124.75%
2 YEAR CAGR
37.98%
5 YEAR CAGR
16.65%
10 YEAR CAGR